Nodal Positive Urothelial Cancer of the Bladder: High CD10 Expression in Primary Tumor Independently Predicts Favorable Survival in Surgically Treated Patients

被引：0

作者：

Seiler, R. ^{[1
]}

von Gunten, M. ^{[1
]}

Thalmann, G. N. ^{[1
]}

Fleischmann, A. ^{[1
]}

机构：

[1] Univ Bern, Bern, Switzerland

来源：

MODERN PATHOLOGY | 2010年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

974

引用

页码：218A / 218A

页数：1

共 50 条

[41] CD68-positive tumor-associated macrophages predicts the survival of patients with stage I colorectal cancer
Liu, Xiaomei
Liu, Heng
Yuan, Caijun
Zhang, Yinxu
Wang, Yu
Hu, Shuding
Liu, Lei
Wang, Ying
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (11): : 11676 - 11681
[42] High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Si-Qi Qiu
Johan van Rooijen
Hilde H. Nienhuis
Bert van der Vegt
Hetty Timmer-Bosscha
Elise van Leeuwen-Stok
Annemiek M. E. Walenkamp
Carolien H. M. van Deurzen
Geertruida H. de Bock
Elisabeth G. E. de Vries
Carolien P. Schröder
Breast Cancer Research, 22
[43] High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
Qiu, Si-Qi
van Rooijen, Johan
Nienhuis, Hilde H.
van der Vegt, Bert
Timmer-Bosscha, Hetty
van Leeuwen-Stok, Elise
Walenkamp, Annemiek M. E.
van Deurzen, Carolien H. M.
de Bock, Geertruida H.
de Vries, Elisabeth G. E.
Schroder, Carolien P.
BREAST CANCER RESEARCH, 2020, 22 (01)
[44] Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas
Gunia, Sven
Jain, Anjun
Koch, Stefan
Denzinger, Stefan
Goetz, Stefanie
Niessl, Nina
May, Matthias
JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (04) : 297 - 301
[45] High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients
Cheng, Yu-Jen
Lee, Yi-Chen
Chiu, Wen-Chin
Tsai, Jen-Wei
Su, Yu-Han
Hung, Amos C.
Chang, Po-Chih
Huang, Chih-Jen
Chai, Chee-Yin
Yuan, Shyng-Shiou F.
ONCOTARGET, 2014, 5 (22) : 11564 - 11575
[46] Editorial Comment to High neutrophil-to-lymphocyte ratio predicts worse overall survival in patients with advanced/metastatic urothelial bladder cancer
Ohno, Yoshio
INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (03) : 238 - 239
[47] High stromal CD39 expression is a strong prognostic factor for longer survival in ≥ pT2 urothelial bladder cancer
Ledderose, S.
Rodler, S.
Eismann, L.
Klauschen, F.
Rudelius, M.
Sendelhofert, A.
Ledderose, C.
VIRCHOWS ARCHIV, 2024, 485 : S171 - S172
[48] PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
Abu Sabbah, Tanja
Theurer, Sarah
Baba, Hideo Andreas
Lueong, Smiths
Rashidi-Alavijeh, Jassin
Hilser, Thomas
Zaun, Yasmin
Metzenmacher, Martin
Pogorzelski, Michael
Virchow, Isabel
Pretzell, Ina
Kostbade, Karina
Treckmann, Jurgen
Wiesweg, Marcel
Schuler, Martin
Kasper, Stefan
Zaun, Gregor
EUROPEAN JOURNAL OF CANCER, 2024, 210
[49] Association Between Local Radiation Therapy to the Primary Bladder Tumor and Overall Survival for Patients with Metastatic Urothelial Cancer Receiving Systemic Chemotherapy
Fischer-Valuck, Benjamin W.
Patel, Sagar A.
Brenneman, Randall J.
Christodouleas, John
Sargos, Paul
Kim, Eric
Weiss, Aaron
Hershatter, Bruce
Rao, Yuan J.
Picus, Joel
Roth, Bruce
Arora, Vivek
Carmona, Ruben
Reimers, Melissa
Zaghloul, Mohamed S.
Gay, Hiram
Michalski, Jeff M.
Baumann, Brian C.
EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (02): : 246 - 250
[50] Increased DHRS12 expression independently predicts poor survival in patients with high-grade serous ovarian cancer
Zhang, Yan
Wu, Jiang
Jing, Hong
Huang, Gui
Dong, Jinlong
Cui, Zhanjun
FUTURE ONCOLOGY, 2018, 14 (25) : 2579 - 2588

← 1 2 3 4 5 →